RANI

Rani Therapeutics Holdings, Inc.

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Imran TalatDirector, Officer: Chief Executive Officer
--3.8M shares
Grant / ExerciseJun 3, 2026
$3.3M3.8M shares
$0.875
$0.9515
Javadi AlirezaChief Technical Officer
--805.5k shares
Grant / ExerciseJun 3, 2026
$704.8K805.5k shares
$0.875
$0.9515
McKinley KateChief Business Officer
--805.5k shares
Grant / ExerciseJun 3, 2026
$704.8K805.5k shares
$0.875
$0.9515

News

globenewswire.comRani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rulesglobenewswire.comMay 26globenewswire.comRani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transitionglobenewswire.comMay 15globenewswire.comRani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conferenceglobenewswire.comMay 12globenewswire.comRani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategyglobenewswire.comApr 9seekingalpha.comRani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcriptseekingalpha.comMar 26